Table 6 (Continued)
Out-of-Sample 12-month-Ahead Forecasting Results
VAR(1) on Yield Changes
|
Maturity ( τ ) |
Mean |
Std. Dev. |
RMSE |
P(12) |
P(24) |
|
3 months |
0.717 |
1.072 |
1.290 |
-0.068 |
-0.127 |
|
1 year |
0.704 |
1.240 |
1.426 |
-0.223 |
-0.041 |
|
3 years |
0.627 |
1.341 |
1.480 |
-0.399 |
0.051 |
|
5 years |
0.559 |
1.281 |
1.398 |
-0.459 |
0.070 |
|
10 years |
0.408 |
1.136 |
1.207 |
-0.491 |
0.072 |
ECM(1) with one Common Trend
|
Maturity (j) |
Mean |
Std. Dev. |
RMSE |
P(12) |
P(24) |
|
3 months |
0.738 |
0.982 |
1.228 |
-0.163 |
-0.123 |
|
1 year |
0.767 |
1.143 |
1.376 |
-0.239 |
-0.072 |
|
3 years |
0.546 |
1.203 |
1.321 |
-0.278 |
-0.013 |
|
5 years |
0.379 |
1.191 |
1.250 |
-0.278 |
-0.003 |
|
10 years |
0.169 |
1.095 |
1.108 |
-0.224 |
0.009 |
ECM(1) with Two Common Trends
|
Maturity (j) |
Mean |
Std. Dev. |
RMSE |
P(12) |
P(24) |
|
3 months |
0.778 |
1.037 |
1.296 |
-0.175 |
-0.129 |
|
1 year |
0.868 |
1.247 |
1.519 |
-0.286 |
-0.033 |
|
3 years |
0.586 |
1.186 |
1.323 |
-0.288 |
-0.034 |
|
5 years |
0.425 |
1.155 |
1.231 |
-0.304 |
-0.014 |
|
10 years |
0.220 |
1.035 |
1.058 |
-0.274 |
0.015 |
Direct Regression on Three AR(1) Principal Components
|
Maturity (j) |
Mean |
Std. Dev. |
RMSE |
P(12) |
P(24) |
|
3 months |
0.162 |
0.785 |
0.802 |
-0.298 |
-0.020 |
|
1 year |
0.416 |
0.979 |
1.064 |
-0.305 |
0.042 |
|
3 years |
-0.127 |
1.014 |
1.022 |
-0.372 |
0.054 |
|
5 years |
-0.393 |
1.013 |
1.087 |
-0.335 |
0.038 |
|
10 years |
-0.394 |
0.929 |
1.009 |
-0.284 |
0.066 |
More intriguing information
1. Road pricing and (re)location decisions households2. The name is absent
3. EMU's Decentralized System of Fiscal Policy
4. The name is absent
5. Evaluation of the Development Potential of Russian Cities
6. The economic value of food labels: A lab experiment on safer infant milk formula
7. The Role of Immigration in Sustaining the Social Security System: A Political Economy Approach
8. The name is absent
9. Placenta ingestion by rats enhances y- and n-opioid antinociception, but suppresses A-opioid antinociception
10. THE ECONOMICS OF COMPETITION IN HEALTH INSURANCE- THE IRISH CASE STUDY.